ICU Medical, Inc. with ticker code (ICUI) have now 2 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 216 and 210 calculating the mean target price we have $213.00. Given that the stocks previous close was at $191.77 this indicates there is a potential upside of 11.1%. It’s also worth noting that there is a 50 day moving average of $176.90 and the 200 day moving average is $166.30. The company has a market cap of 4.45B. The current stock price for Targa Resources Corp. is currently 184.93 USD
The potential market cap would be $4,942,894,247 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 96.22 and a 0.33% return on assets.
ICU Medical, Inc. develops, manufactures and sells medical products used in infusion therapy, vascular access, and vital care applications. The Company’s product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its primary Infusion System products are dedicated IV sets and others. Its primary IV Solutions products include IV Therapy and Diluents and Irrigation. Its primary Critical Care products include Cogent 2-in-1 hemodynamic monitoring system; CardioFlo hemodynamic monitoring system; TDQ and OptiQ cardiac output monitoring catheters; TriOxTM venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation system.
